Ads
related to: sars-cov treatment
Search results
Scientists Race To Perfect New Oral COVID-19 Treatment Poised To Replace Paxlovid
SciTechDaily· 9 hours agoRutgers researchers are advancing a potential new COVID-19 treatment, Jun12682, which is effective in animal studies and compatible with other medications, unlike the current ...
Analyzing The Emergence Of Covid Variant KP.2 And Its Potential Impact
Forbes· 3 days agoLike influenza, an easily transmissible respiratory virus, SARS-CoV-2 mutates to evade the immune...
Researchers take step toward development of universal COVID-19 antibodies
KTBS Shreveport· 4 days agoSARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists ...
Medications to Treat Upper Respiratory Infections
Healthline· 5 days agoMedications such as nasal decongestants and cough suppressants may help manage symptoms of upper respiratory infections. A respiratory infection affects...
‘I took an oath to do no harm’: The two doctors wrestling over Fauci’s legacy
Washington Post via Yahoo News· 16 hours agoBrad Wenstrup was alarmed. It was February 2020, weeks before the coronavirus pandemic shuttered...
Antidepressant-induced membrane trafficking regulates blood-brain barrier permeability - Molecular...
Nature· 4 days agoAs the most prescribed psychotropic drugs in current medical practice, antidepressant drugs (ADs) of the selective serotonin reuptake inhibitor (SSRI) class represent prime candidates for drug ...
... Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID,...
Morningstar· 5 days ago(NYSE American:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its development of a first-in-class, broad-spectrum antiviral agent ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoFood and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations (EUAs) for serial, novel monoclonal antibodies (mAbs) for ...
Could a Fungal Infection Cause a Future Pandemic?
Medscape· 5 days agoThe maxim of resilience and survival is key for medically important fungi, and although these microorganisms are far from recreating the postapocalyptic...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 3 days agoInvivyd Inc. (NASDAQ: IVVD), a biopharmaceutical company, has announced an agreement with the U.S....